Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017:2017:7942515.
doi: 10.1155/2017/7942515. Epub 2017 Feb 26.

Nitazoxanide in Acute Rotavirus Diarrhea: A Randomized Control Trial from a Developing Country

Samarendra Mahapatro  1 , Nijwm Mahilary  2 , Amit Kumar Satapathy  1 , Rashmi Ranjan Das  1
Affiliations

Nitazoxanide in Acute Rotavirus Diarrhea: A Randomized Control Trial from a Developing Country

Samarendra Mahapatro et al. J Trop Med. 2017.

Abstract

Background. Acute diarrhea is one of the leading causes of childhood mortality, with rotavirus being an important pathogen. Nitazoxanide, an antiparasitic agent, has been shown to inhibit rotavirus. Objective. This double-blind, randomized trial was designed to study the role of nitazoxanide in acute rotavirus diarrhea. Methods. Of 174 children (12 months to 5 years) with acute diarrhea, 50 rotavirus positive cases were randomized. The intervention group received syrup nitazoxanide twice daily (100 mg in 12-47 months, 200 mg in ≥4 yr) for 3 days along with standard treatment of diarrhea. Duration of diarrhea was the primary outcome measure. Results. The median duration (hrs) of diarrhea (54 versus 80; 95% CI: -26 [-13.2 to -38.8]) and hospitalization (68 versus 90; 95% CI: -22 [-12.98 to -31.02]) was significantly shorter in the nitazoxanide group. No significant difference was seen in the median duration (hrs) of fever or vomiting or the proportion of children requiring parenteral rehydration. There was no report of any adverse events. Conclusions. Oral nitazoxanide is effective and safe in the management of acute rotavirus diarrhea in Indian children (CTRI REF/2016/10/012507).

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no competing interests.

Figures

Figure 1
Figure 1
Flow of participants in the study.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Rudan I., O'Brien K. L., Nair H., et al. Epidemiology and etiology of childhood pneumonia in 2010: estimates of incidence, severe morbidity, mortality, underlying risk factors and causative pathogens for 192 countries. Journal of Global Health. 2010;3(1)010401 - PMC - PubMed
    1. Shah D., Choudhury P., Gupta P., et al. Promoting appropriate management of diarrhea: a systematic review of literature for advocacy and action: UNICEF-PHFI series on Newborn and child health, India. Indian Pediatrics. 2012;49(8):627–649. doi: 10.1007/s13312-012-0134-1. - DOI - PubMed
    1. Kotloff K. L., Nataro J. P., Blackwelder W. C., et al. Burden and aetiology of diarrhoeal disease in infants and young children in developing countries (the Global Enteric Multicenter Study, GEMS): a prospective, case-control study. The Lancet. 2013;382(9888):209–222. doi: 10.1016/s0140-6736(13)60844-2. - DOI - PubMed
    1. Kang G., Arora R., Chitambar S. D., et al. Multicenter, hospital-based surveillance of rotavirus disease and strains among Indian children aged <5 years. Journal of Infectious Diseases. 2009;200(1):S147–S153. doi: 10.1086/605031. - DOI - PubMed
    1. Yen C., Tate J. E., Hyde T. B., et al. Rotavirus vaccines: current status and future considerations. Human Vaccines and Immunotherapeutics. 2014;10(6):1436–1448. doi: 10.4161/hv.28857. - DOI - PMC - PubMed

LinkOut - more resources